News
Larotrectinib
Zhonghan Biotech's Abemaciclib Intermediates: High-Quality Key Intermediates Empowering Efficient Synthesis of CDK4/6 Inhibitors
As an orally highly selective CDK4/6 inhibitor, Abemaciclib is a core targeted drug for the treatment of HR+/HER2- breast cancer, widely used in the clinical treatment of locally advanced and metastatic breast cancer. Its synthesis chain has stringent requirements for the purity, stability and batch consistency of key intermediates, which directly determine the quality of active pharmaceutical ingredients (APIs) and the safety of preparations.
Getting Excellent Feedback About The Order of JIS Standard Stainless Steel Flanged Ball Valves Shipped to Vietnam
Zhonghan Biomedical Technology (R)-2-(2, 5-difluorophenyl) pyrrolidine preparation method patent was officially authorized
Zhonghan (Qihe County) Biomedical Technology Co., Ltd. welcomed the good news! On June 14, 2024, the State Intellectual Property Office officially issued a notice announcing that the company's patent for a preparation method of (R)-2-(2, 5-difluorophenyl) pyrrolidine has been successfully authorized.
The company has been selected as a project for enhancing the innovation capability of technology-based small and medium-sized enterprises in Shandong Province
In November 2021, the Science and Technology Department of Shandong Province announced the first batch of approved projects for the 2021 Shandong Province Science and Technology based Small and Medium sized Enterprise Innovation Capability Enhancement Project, and Zhonghan (Qihe County) Biomedical Technology Co., Ltd. was honored to be selected.
The company has passed ISO9001 quality management system certification, taking quality management to a new level
In June 2024, the company announced that it had once again successfully passed the ISO9001 quality management system certification, following its certification in 2021. This marks significant achievements in quality management and further enhances its competitiveness and market position in the industry.